30 September 2021
GREENCOAT UK WIND PLC
Completion of Commissioning of Douglas West
Greencoat UK Wind PLC (the "Company", or "UKW") is pleased to announce that the commissioning of Douglas West wind farm has been completed.
Douglas West is a 45MW wind farm located 7 miles south-west of Lanark, Scotland and comprises 13 Vestas V136 3.6MW turbines. The addition of Douglas West increases UKW's net generating capacity to 1,289MW and is the first subsidy free asset in the portfolio.
The acquisition was first announced in December 2018 and the project has been funded through reinvestment of UKW's excess cash flow.
For further information, please contact:
Greencoat UK Wind PLC 020 7832 9425
Headland Consultancy 020 3805 4822
Notes to Editors:
Greencoat UK Wind PLC is the leading listed renewable infrastructure fund, invested in 40 operating UK wind farms with net generating capacity of 1,289MW (including Douglas West). The Company's aim is to provide investors with an annual dividend that increases in line with RPI inflation (7.18p for 2021) while preserving the capital value of its investment portfolio in the long term on a real basis through reinvestment of excess cash flow and the prudent use of gearing.
UKW provides investors with the opportunity to participate directly in the ownership of UK wind farms, so increasing the resources and capital dedicated to the deployment of renewable energy and the reduction of greenhouse gas emissions.
UKW is managed by an experienced team at Greencoat Capital LLP, a leading European renewable investment manager with over £6 billion of assets under management. UKW is governed by a strong and experienced independent board.
UKW is incorporated in England and Wales and is a UK Investment Trust.
For more information about UKW, please visit http://www.greencoat-ukwind.com
For more information about Greencoat Capital LLP, please visit http://www.greencoat-capital.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected]
or visit www.rns.com